Now showing items 1-1 of 1

    Issue DateTitleAuthor(s)
    12 April 2021CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer  Uzor, S; Porazinski, SR; Li, L; et al.